SCHEBO BIOTECH AG

ScheBo Biotech AG is an innovative biotechnology company specializing in the development, production, and marketing of in-vitro diagnostics (IVD). Founded by biochemists Dr. Ursula Scheefers-Borchel and Dr. Hans Scheefers, the company has built over 35 years of expertise delivering unique, clinically validated diagnostic solutions. ScheBo's product portfolio addresses four key clinical specialties: gastroenterology (gastrointestinal disease diagnostics), oncology (cancer diagnostics), veterinary diagnostics, and SARS-CoV-2 diagnostics. The company is internationally active with headquarters in Germany and offices in the USA and UK. ScheBo emphasizes innovation through clinical research and development, positioning its products as gold-standard diagnostic tools with strong unique selling propositions. The company serves clinical laboratories, hospitals, and diagnostic centers globally.